Products based on beta vulgaris and especially red beet and methods for producing the same are provided. The orally administered beta vulgaris based products are adapted to be used for reducing homocysteine levels as well as reducing the cholesterol levels in the blood among other therapeutic effects.

 
Web www.patentalert.com

< Tri ascorbate formulation

> Cosmetic or Dermopharmaceutical Composition Comprising an Euglena Extract

~ 00490